MX10490A - Procedimiento para la preparacion de un producto de retardo, que contiene diltizem, para una administracion diaria unica. - Google Patents

Procedimiento para la preparacion de un producto de retardo, que contiene diltizem, para una administracion diaria unica.

Info

Publication number
MX10490A
MX10490A MX1049088A MX1049088A MX10490A MX 10490 A MX10490 A MX 10490A MX 1049088 A MX1049088 A MX 1049088A MX 1049088 A MX1049088 A MX 1049088A MX 10490 A MX10490 A MX 10490A
Authority
MX
Mexico
Prior art keywords
preparation
diltizem
procedure
daily administration
single daily
Prior art date
Application number
MX1049088A
Other languages
English (en)
Inventor
Dieter Barth
Original Assignee
Varnel Chem Business Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Varnel Chem Business Sa filed Critical Varnel Chem Business Sa
Publication of MX10490A publication Critical patent/MX10490A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX1049088A 1987-02-20 1988-02-19 Procedimiento para la preparacion de un producto de retardo, que contiene diltizem, para una administracion diaria unica. MX10490A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH63787 1987-02-20

Publications (1)

Publication Number Publication Date
MX10490A true MX10490A (es) 1993-12-01

Family

ID=4191649

Family Applications (1)

Application Number Title Priority Date Filing Date
MX1049088A MX10490A (es) 1987-02-20 1988-02-19 Procedimiento para la preparacion de un producto de retardo, que contiene diltizem, para una administracion diaria unica.

Country Status (12)

Country Link
EP (1) EP0282698B1 (es)
JP (1) JP2863528B2 (es)
KR (1) KR960011232B1 (es)
AT (1) ATE172112T1 (es)
AU (1) AU1196988A (es)
BR (1) BR8800763A (es)
CA (1) CA1327006C (es)
DE (1) DE3856258T2 (es)
DK (1) DK173505B1 (es)
ES (1) ES2125215T3 (es)
MX (1) MX10490A (es)
ZA (1) ZA881181B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3737741A1 (de) * 1987-11-06 1989-05-18 Goedecke Ag Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid
DE3922167A1 (de) * 1988-04-16 1991-01-17 Sanol Arznei Schwarz Gmbh Oral zu verabreichende diltiazemhydrochlorid enthaltende pharmazeutische zubereitung zur einmal taeglichen applikation und verfahren zu deren herstellung
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
SE8902699D0 (sv) * 1989-08-09 1989-08-09 Lejus Medical Ab Diltiazem containing pharmaceutical compositios
US5286497A (en) * 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation
ZA923474B (en) * 1991-05-20 1993-01-27 Marion Merrell Dow Inc Diltiazem formulation
JP3746315B2 (ja) 1994-07-07 2006-02-15 ダイセル化学工業株式会社 分離剤
US5834024A (en) * 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
CN100475210C (zh) * 1996-03-08 2009-04-08 尼科梅德丹麦有限公司 改进释放的多单位剂量组合物
US5830503A (en) * 1996-06-21 1998-11-03 Andrx Pharmaceuticals, Inc. Enteric coated diltiazem once-a-day formulation
FR2754710B1 (fr) * 1996-10-22 1998-12-31 Prographarm Lab Procede de preparation d'une forme pharmaceutique multiparticulaire a liberation controlee plurisequentielle
WO1999067013A1 (fr) 1996-12-10 1999-12-29 Asahi Kasei Kogyo Kabushiki Kaisha Film poreux d'une resine de fluorure de polyvinylidene et son procede de production
US6162463A (en) * 1997-05-01 2000-12-19 Dov Pharmaceutical Inc Extended release formulation of diltiazem hydrochloride
US7108866B1 (en) * 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
JPS5867616A (ja) * 1981-10-15 1983-04-22 Tanabe Seiyaku Co Ltd 腸溶性マイクロカプセル
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
FR2554718B1 (fr) * 1983-11-14 1986-04-04 Ethypharm Sa Nouvelles formes galeniques du sulpiride utilisables par voie orale
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
IT1178511B (it) * 1984-09-14 1987-09-09 Pharmatec Spa Procedimento per la preparazione di una forma solida per uso orale a base di nifedipina con rilascio

Also Published As

Publication number Publication date
JP2863528B2 (ja) 1999-03-03
JPH01216934A (ja) 1989-08-30
AU1196988A (en) 1988-08-25
EP0282698A1 (fr) 1988-09-21
ZA881181B (en) 1988-08-16
DE3856258T2 (de) 1999-04-29
DE3856258D1 (de) 1998-11-19
DK173505B1 (da) 2001-01-15
KR960011232B1 (ko) 1996-08-21
EP0282698B1 (fr) 1998-10-14
ES2125215T3 (es) 1999-03-01
CA1327006C (en) 1994-02-15
BR8800763A (pt) 1988-10-04
KR880009640A (ko) 1988-10-04
DK15388D0 (da) 1988-01-13
DK15388A (da) 1988-08-21
ATE172112T1 (de) 1998-10-15

Similar Documents

Publication Publication Date Title
ES2125215T3 (es) Procedimiento para la preparacion de un producto de retardo que contiene diltiazem para una administracion diaria unica.
US4193985A (en) Multiple-units drug dose
UA29563C2 (uk) Мікрокапсула для тривалого вивільнення фізіологічно активного пептиду
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
DE69331409D1 (de) Oral 1alpha-hydroxyprevitamin d
IL96900A0 (en) Pharmaceutical composition containing naproxen
AU2553992A (en) Bone-growth-stimulating composition
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
JPH01500120A (ja) 老化抑制の為の薬剤組成物
NZ218734A (en) Tablets containing coated microspheres which contain ibuprofen (2-(4-isobutyl phenyl)propanoic acid)
JP2893307B2 (ja) ニコランジルの製薬的に安定な製剤
KR830002510A (ko) 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물
HK134494A (en) Substituted release azelastine containing medicaments
PL317996A1 (en) Carbamazepinic form of a drug with retarded release of biologically active substance
DE59204281D1 (de) Ein ibuprofen enthaltendes retard-arzneimittel und seine verwendung.
HK1001822A1 (en) Medicinal form for oral application for the once-a-day treatment of hypertension by diltiazem hydrochloride
GB9420748D0 (en) 1,5 benzodiazepine derivatives
ATE322896T1 (de) Verbesserte pharmazeutische zusammensetzung mit einem ppar-alpha-mittel und verfahren zu ihrer herstellung
ATE212840T1 (de) Oral anzuwendende feste arzneizubereitungen mit modulierter wirkstoffabgabe enthaltend nicorandil und verfahren zu deren herstellung
RU96123569A (ru) Лекарственный препарат
KR970000241A (ko) 발히마이신의 동물 성장 촉진제로서의 용도 및 촉진제 조성물
MY114610A (en) Controlled drug delivery system for diltiazem.